immediate action Recalls
2,756 recalls tagged with “immediate action”.
Merit Medical's DuraMax 16F Hemodialysis Catheter Recalled For Splittable Sheath Defect (2026)
16F dual-valved splittable sheath introducer due to a design defect, may not split as intended, which may result in hemorrhage, foreign bodies, and procedure delay.
Medline ENFIT G-Tube Connector ENFIT1010GC Recalled for Leakage Risk (651,789 Units, 2026)
Medtronic MiniMed 740G Insulin Pump Recalled for 24,946 Units Worldwide (2026)
Medtronic MiniMed Paradigm Revel Insulin Pumps Recalled: 26,647 Units Worldwide (2026)
Medtronic MiniMed 720G Insulin Pump Recall 2026 Affects 37,458 Units Worldwide
Medtronic MiniMed Paradigm Veo Insulin Pump Recalled for 55,724 Units (2026)
Merit Medical ProGuide 16F Dialysis Sheath Introducer Recalled Worldwide in 2026 (131 Units)
16F dual-valved splittable sheath introducer due to a design defect, may not split as intended, which may result in hemorrhage, foreign bodies, and procedure delay.
Merit Medical BioFlo DuraMax Catheter Recall 2026: 47,153 Units Worldwide
16F dual-valved splittable sheath introducer due to a design defect, may not split as intended, which may result in hemorrhage, foreign bodies, and procedure delay.
Medtronic MiniMed Recalled 116,645 Insulin Pumps Over Delivery Risk (2026)
Medtronic MiniMed 620G Insulin Pump Recall Impacts 799 Units Worldwide (2026)
Medtronic MiniMed 700G Insulin Pump Recalled for Insulin Delivery Errors (13,811 Units, 2026)
Medtronic MiniMed Paradigm Real-Time Insulin Pump Recalled for 29,074 Units Worldwide (2026)
Medtronic MiniMed Paradigm Insulin Pumps Recalled 73,656 Units Worldwide in 2026
Medline ENFIT G-Tube Connector Kits Recalled for Leakage Risk in 2026
Medtronic MiniMed 630G Insulin Pumps Recalled in 2026 for Insulin Delivery Errors (60,880 Units)
Medtronic MiniMed 770G Insulin Pump Recall Affects 95,704 Units Worldwide (2026)
Ambrosia Brands Rosabella Moringa Capsules Recalled for Salmonella Contamination (1,224,208 Units)
Product may be contaminated with Salmonella
Harbin Jixianglong Biotech Semaglutide Rx Compounding Recall (2026)
CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution
Harbin Jixianglong Biotech Semaglutide Rx Compounding Recall 2026 — 6 Packaging Sizes
CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution